{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:06:43Z","timestamp":1781770003982,"version":"3.54.5"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s40272-023-00570-1","type":"journal-article","created":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T09:02:38Z","timestamp":1683968558000},"page":"411-424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pediatric Status Epilepticus: Treat Early and Avoid Delays"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2206-5561","authenticated-orcid":false,"given":"Lindsey A.","family":"Morgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3672-0758","authenticated-orcid":false,"given":"Jennifer B.","family":"Hrachovec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0528-4949","authenticated-orcid":false,"given":"Howard P.","family":"Goodkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,13]]},"reference":[{"issue":"9531","key":"570_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0140-6736(06)69043-0","volume":"368","author":"RF Chin","year":"2006","unstructured":"Chin RF, Neville BG, Peckham C, et al. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet. 2006;368(9531):222\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(06)69043-0.","journal-title":"Lancet"},{"issue":"4","key":"570_CR2","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1212\/WNL.46.4.1029","volume":"46","author":"RJ DeLorenzo","year":"1996","unstructured":"DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46(4):1029\u201335. https:\/\/doi.org\/10.1212\/WNL.46.4.1029.","journal-title":"Neurology"},{"issue":"2","key":"570_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12245-008-0024-4","volume":"1","author":"DJ Pallin","year":"2008","unstructured":"Pallin DJ, Goldstein JN, Moussally JS, et al. Seizure visits in US emergency departments: epidemiology and potential disparities in care. Int J Emerg Med. 2008;1(2):97\u2013105. https:\/\/doi.org\/10.1007\/s12245-008-0024-4.","journal-title":"Int J Emerg Med"},{"key":"570_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.seizure.2021.02.020","volume":"87","author":"I S\u00e1nchez Fern\u00e1ndez","year":"2012","unstructured":"S\u00e1nchez Fern\u00e1ndez I, Amengual-Gual M, Barcia Aguilar C, et al. Descriptive epidemiology and health resource utilization for status epilepticus in the emergency department in the United States of America. Seizure. 2012;87:7\u201316. https:\/\/doi.org\/10.1016\/j.seizure.2021.02.020.","journal-title":"Seizure."},{"key":"570_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb02070.x","author":"RJ DeLorenzo","year":"1999","unstructured":"DeLorenzo RJ, Garnett LK, Towne AR, et al. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia. 1999. https:\/\/doi.org\/10.1111\/j.1528-1157.1999.tb02070.x.","journal-title":"Epilepsia"},{"issue":"9","key":"570_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S1474-4422(06)70546-4","volume":"5","author":"M Raspall-Chaure","year":"2006","unstructured":"Raspall-Chaure M, Chin RFM, Neville BG, et al. Outcome of paediatric convulsive status epilepticus: a systematic review. Lancet Neurol. 2006;5(9):769\u201379. https:\/\/doi.org\/10.1016\/S1474-4422(06)70546-4.","journal-title":"Lancet Neurol"},{"key":"570_CR7","doi-asserted-by":"publisher","DOI":"10.5698\/1535-7597-16.1.48","author":"T Glauser","year":"2016","unstructured":"Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. Epilepsy Curr. 2016. https:\/\/doi.org\/10.5698\/1535-7597-16.1.48.","journal-title":"Epilepsy Curr."},{"key":"570_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-012-9695-z","author":"GM Brophy","year":"2012","unstructured":"Brophy GM, Bell R, Claasen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012. https:\/\/doi.org\/10.1007\/s12028-012-9695-z.","journal-title":"Neurocrit Care."},{"issue":"5","key":"570_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/ana.1018","volume":"49","author":"S Shinnar","year":"2001","unstructured":"Shinnar S, Berg AT, Moshe SL, et al. How long do new-onset seizures in children last? Ann Neurol. 2001;49(5):659\u201364.","journal-title":"Ann Neurol"},{"issue":"1","key":"570_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1046\/j.1535-7597.2003.03104.x","volume":"3","author":"HP Goodkin","year":"2003","unstructured":"Goodkin HP, Kapur J. Responsiveness of status epilepticus to treatment with diazepan decreases rapidly as seizure duration increases. Epilepsy Curr. 2003;3(1):11\u20132. https:\/\/doi.org\/10.1046\/j.1535-7597.2003.03104.x.","journal-title":"Epilepsy Curr."},{"key":"570_CR11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010174","author":"I S\u00e1nchez Fern\u00e1ndez","year":"2020","unstructured":"S\u00e1nchez Fern\u00e1ndez I, Abend NS, Amengual-Gual M, et al. Association of guideline publication and delays to treatment in pediatric status epilepticus. Neurology. 2020. https:\/\/doi.org\/10.1212\/WNL.0000000000010174.","journal-title":"Neurology"},{"issue":"23","key":"570_CR12","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1212\/WNL.0000000000001673","volume":"84","author":"I Sanchez Fernandez","year":"2015","unstructured":"Sanchez Fernandez I, Abend NS, Agadi S, et al. Time from convulsive status epilepticus onset to anticonvulsant administration in children. Neurology. 2015;84(23):2304\u201311. https:\/\/doi.org\/10.1212\/WNL.0000000000001673.","journal-title":"Neurology"},{"issue":"3","key":"570_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/epi.12526","volume":"55","author":"S Seinfeld","year":"2014","unstructured":"Seinfeld S, Shinnar S, Sun S, et al. Emergency management of febrile status epilepticus: results of the FEBSTAT study. Epilepsia. 2014;55(3):388\u201395. https:\/\/doi.org\/10.1111\/epi.12526.","journal-title":"Epilepsia"},{"issue":"11","key":"570_CR14","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1111\/epi.17043","volume":"62","author":"T Sheehan","year":"2021","unstructured":"Sheehan T, et al. Benzodiazepine administration patterns before escalation to second-line medications in pediatric refractory convulsive status epilepticus. Epilepsia. 2021;62(11):2766\u201377. https:\/\/doi.org\/10.1111\/epi.17043.","journal-title":"Epilepsia"},{"issue":"19","key":"570_CR15","doi-asserted-by":"publisher","first-page":"e2683","DOI":"10.1212\/WNL.0000000000010828","volume":"95","author":"A Vasquez","year":"2020","unstructured":"Vasquez A, Ga\u00ednza-Lein M, Abend NS, et al. First-line medication dosing in pediatric refractory status epilepticus. Neurology. 2020;95(19):e2683\u201396. https:\/\/doi.org\/10.1212\/WNL.0000000000010828.","journal-title":"Neurology"},{"issue":"5","key":"570_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/1535759720928269","volume":"20","author":"DG Vossler","year":"2020","unstructured":"Vossler DG, Bainbridge JL, Boggs JG, et al. Treatment of refractory convulsive status epilepticus: a comprehensive review by the American Epilepsy Society Treatments Committee. Epilepsy Curr. 2020;20(5):245\u201364. https:\/\/doi.org\/10.1177\/1535759720928269.","journal-title":"Epilepsy Curr."},{"issue":"6","key":"570_CR17","doi-asserted-by":"publisher","first-page":"153575972199967","DOI":"10.1177\/1535759721999670","volume":"21","author":"JG Ochoa","year":"2021","unstructured":"Ochoa JG, Dougherty M, Papanastassiou A, et al. Treatment of super-refractory status epilepticus: a review. Epilepsy Curr. 2021;21(6):1535759721999670. https:\/\/doi.org\/10.1177\/1535759721999670.","journal-title":"Epilepsy Curr."},{"issue":"12","key":"570_CR18","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/j.1468-1331.2004.00943.x","volume":"11","author":"RFM Chin","year":"2004","unstructured":"Chin RFM, Neville BGR, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol. 2004;11(12):800\u201310. https:\/\/doi.org\/10.1111\/j.1468-1331.2004.00943.x.","journal-title":"Eur J Neurol"},{"issue":"3","key":"570_CR19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1474-4422(06)70374-X","volume":"5","author":"JWY Chen","year":"2006","unstructured":"Chen JWY, Wasterlain CG. Status epilepticus: pathophysiology and management in adults. Lancet Neurol. 2006;5(3):246\u201356. https:\/\/doi.org\/10.1016\/S1474-4422(06)70374-X.","journal-title":"Lancet Neurol"},{"key":"570_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yebeh.2014.05.018","volume":"37","author":"I S\u00e1nchez Fern\u00e1ndez","year":"2014","unstructured":"S\u00e1nchez Fern\u00e1ndez I, Vendrame M, Kapur K, et al. Comparison of pediatric patients with status epilepticus lasting 5\u201329 min versus \u2265 30 min. Epilepsy Behav. 2014;37:1\u20136. https:\/\/doi.org\/10.1016\/j.yebeh.2014.05.018.","journal-title":"Epilepsy Behav."},{"issue":"6","key":"570_CR21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1097\/MOP.0000000000000825","volume":"31","author":"S Pujar","year":"2019","unstructured":"Pujar S, Scott RC. Long-term outcomes after childhood convulsive status epilepticus. Curr Opin Pediatr. 2019;31(6):763\u20138. https:\/\/doi.org\/10.1097\/MOP.0000000000000825.","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"570_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S2352-4642(17)30174-8","volume":"2","author":"SS Pujar","year":"2018","unstructured":"Pujar SS, Martinos MM, Cortina-Borja M, et al. Long-term prognosis after childhood convulsive status epilepticus: a prospective cohort study. Lancet Child Adolesc Health. 2018;2(2):103\u201311. https:\/\/doi.org\/10.1016\/S2352-4642(17)30174-8.","journal-title":"Lancet Child Adolesc Health."},{"key":"570_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.yebeh.2019.03.039","volume":"95","author":"MM Martinos","year":"2019","unstructured":"Martinos MM, Pujar S, O\u2019Reilly H, et al. Intelligence and memory outcomes within 10 years of childhood convulsive status epilepticus. Epilepsy Behav. 2019;95:18\u201325. https:\/\/doi.org\/10.1016\/j.yebeh.2019.03.039.","journal-title":"Epilepsy Behav"},{"key":"570_CR24","doi-asserted-by":"publisher","unstructured":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia. 1981;22(4):489\u2013501. https:\/\/doi.org\/10.1111\/j.1528-1157.1981.tb06159.x.","DOI":"10.1111\/j.1528-1157.1981.tb06159.x"},{"issue":"1","key":"570_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/archneur.1973.00490190019001","volume":"28","author":"BS Meldrum","year":"1973","unstructured":"Meldrum BS, Horton RW. Physiology of status epilepticus in primates. Arch Neurol. 1973;28(1):1\u20139. https:\/\/doi.org\/10.1001\/archneur.1973.00490190019001.","journal-title":"Arch Neurol"},{"issue":"5","key":"570_CR26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/WNP.0000000000000711","volume":"37","author":"S Joshi","year":"2020","unstructured":"Joshi S, Goodkin HP. The need to intervene before time point 2: evidence from clinical and animal data that status epilepticus damages the brain. J Clin Neurophysiol. 2020;37(5):375\u201380. https:\/\/doi.org\/10.1097\/WNP.0000000000000711.","journal-title":"J Clin Neurophysiol"},{"issue":"5 Suppl 2","key":"570_CR27","first-page":"13","volume":"40","author":"E Lothman","year":"1990","unstructured":"Lothman E. The biochemical basis and pathophysiology of status epilepticus. Neurology. 1990;40(5 Suppl 2):13\u201323.","journal-title":"Neurology"},{"issue":"1","key":"570_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1528-1157.1999.tb02000.x","volume":"40","author":"DH Lowenstein","year":"1999","unstructured":"Lowenstein DH, Bleck T, Macdonald RL. It\u2019s time to revise the definition of status epilepticus. Epilepsia. 1999;40(1):120\u20132. https:\/\/doi.org\/10.1111\/j.1528-1157.1999.tb02000.x.","journal-title":"Epilepsia"},{"issue":"10","key":"570_CR29","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","volume":"56","author":"E Trinka","year":"2015","unstructured":"Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus\u2014report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56(10):1515\u201323. https:\/\/doi.org\/10.1111\/epi.13121.","journal-title":"Epilepsia"},{"issue":"9","key":"570_CR30","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1111\/j.1528-1167.2009.02257.x","volume":"50","author":"HP Goodkin","year":"2009","unstructured":"Goodkin HP, Kapur J. The impact of diazepam\u2019s discovery on the treatment and understanding of status epilepticus. Epilepsia. 2009;50(9):2011\u20138. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02257.x.","journal-title":"Epilepsia"},{"issue":"Suppl 9","key":"570_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/epi.12037","volume":"53","author":"TZ Deeb","year":"2012","unstructured":"Deeb TZ, Maguire J, Moss SJ. Possible alterations in GABAA receptor signaling that underlie benzodiazepine-resistant seizures. Epilepsia. 2012;53(Suppl 9):79\u201388. https:\/\/doi.org\/10.1111\/epi.12037.","journal-title":"Epilepsia"},{"issue":"Suppl 6","key":"570_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/epi.12266","volume":"54","author":"K Rajasekaran","year":"2013","unstructured":"Rajasekaran K, Joshi S, Kozhemyakin M, et al. Receptor trafficking hypothesis revisited: plasticity of AMPA receptors during established status epilepticus. Epilepsia. 2013;54(Suppl 6):14\u20136. https:\/\/doi.org\/10.1111\/epi.12266.","journal-title":"Epilepsia"},{"issue":"Pt 8","key":"570_CR33","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1093\/brain\/aws091","volume":"135","author":"M Ferlisi","year":"2012","unstructured":"Ferlisi M, Shorvon S. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain. 2012;135(Pt 8):2314\u201328. https:\/\/doi.org\/10.1093\/brain\/aws091.","journal-title":"Brain"},{"key":"570_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.seizure.2016.11.001","volume":"44","author":"E Trinka","year":"2017","unstructured":"Trinka E, K\u00e4lvi\u00e4inen R. 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure. 2017;44:65\u201373. https:\/\/doi.org\/10.1016\/j.seizure.2016.11.001.","journal-title":"Seizure."},{"issue":"2","key":"570_CR35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1212\/CON.0000000000001103","volume":"28","author":"E Trinka","year":"2022","unstructured":"Trinka E, Leitinger M. Management of status epilepticus, refractory status epilepticus, and super-refractory status epilepticus. Continuum Lifelong Learn Neurol. 2022;28(2):559\u2013602. https:\/\/doi.org\/10.1212\/CON.0000000000001103.","journal-title":"Continuum Lifelong Learn Neurol."},{"key":"570_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.seizure.2018.05.012","volume":"68","author":"A Vasquez","year":"2019","unstructured":"Vasquez A, Farias-Moeller R, Tatum W. Pediatric refractory and super-refractory status epilepticus. Seizure. 2019;68:62\u201371. https:\/\/doi.org\/10.1016\/j.seizure.2018.05.012.","journal-title":"Seizure."},{"key":"570_CR37","unstructured":"National Institute for Health and Care Excellence (NICE). Epilepsies in children, young people and adults. London; NICE; 2022."},{"issue":"1","key":"570_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/archdischild-2021-323351","volume":"108","author":"M Bacon","year":"2023","unstructured":"Bacon M, Appleton R, Bangalore H, et al. Review of the new APLS guideline (2022): Management of the convulsing child. Arch Dis Child Educ Pract Ed. 2023;108(1):43\u20138. https:\/\/doi.org\/10.1136\/archdischild-2021-323351.","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"7","key":"570_CR39","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1212\/wnl.16.7.629","volume":"16","author":"CT Lombroso","year":"1966","unstructured":"Lombroso CT. Treatment of status epilepticus with diazepam. Neurology. 1966;16(7):629\u201334. https:\/\/doi.org\/10.1212\/wnl.16.7.629.","journal-title":"Neurology"},{"issue":"4","key":"570_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1046\/j.1535-7597.2002.00045.x","volume":"2","author":"J Kapur","year":"2002","unstructured":"Kapur J. Prehospital treatment of status epilepticus with benzodiazepines is effective and safe. Epilepsy Curr. 2002;2(4):121\u20134. https:\/\/doi.org\/10.1046\/j.1535-7597.2002.00045.x.","journal-title":"Epilepsy Curr."},{"issue":"9481","key":"570_CR41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0140-6736(05)66909-7","volume":"366","author":"J McIntyre","year":"2005","unstructured":"McIntyre J, Robertson S, Norris E, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet. 2005;366(9481):205\u201310. https:\/\/doi.org\/10.1016\/S0140-6736(05)66909-7.","journal-title":"Lancet"},{"key":"570_CR42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jconrel.2016.07.001","volume":"237","author":"M Kapoor","year":"2016","unstructured":"Kapoor M, Cloyd JC, Siegel RA. A review of intranasal formulations for the treatment of seizure emergencies. J Control Release. 2016;237:147\u201359. https:\/\/doi.org\/10.1016\/j.jconrel.2016.07.001.","journal-title":"J Control Release"},{"issue":"5","key":"570_CR43","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.annemergmed.2016.08.450","volume":"69","author":"DS Tsze","year":"2017","unstructured":"Tsze DS, Ieni M, Fenster DB, et al. Optimal volume of administration of intranasal midazolam in children: a randomized clinical trial. Ann Emerg Med. 2017;69(5):600\u20139. https:\/\/doi.org\/10.1016\/j.annemergmed.2016.08.450.","journal-title":"Ann Emerg Med"},{"key":"570_CR44","unstructured":"MAD Nasal Device Procedure Guide. Teleflex, IN. Morrisville, NC. https:\/\/teleflex.com\/usa\/en\/product-areas\/anesthesia\/atomization\/mad-nasal-device\/AN_ATM_Anesthesia-MAD-Nasal-User-Guide_MC_MC-001925_Rev1.pdf#search='mad%20nasal%20device%20procedure%20guide. Accessed 17 Mar 2023."},{"key":"570_CR45","unstructured":"Valtoco Package Insert. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/211635s000lbl.pdf. Accessed 17 Mar 2023."},{"key":"570_CR46","unstructured":"Getzoff N. Clinical Review NDA 211635 Valtoco (Diazepam nasal spray). Center for Drug Evaluation and Research; 2020. p. 1\u201349."},{"issue":"3","key":"570_CR47","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/epi.16449","volume":"61","author":"RE Hogan","year":"2020","unstructured":"Hogan RE, Gidal BE, Koplowitz B, et al. Bioavailability and safety of diazepam intranasal solution compared to oral and rectal diazepam in healthy volunteers. Epilepsia. 2020;61(3):455\u201364. https:\/\/doi.org\/10.1111\/epi.16449.","journal-title":"Epilepsia"},{"key":"570_CR48","unstructured":"NAYZILAM\u00ae (midazolam) nasal spray, CIV n.d. https:\/\/www-accessdata-fda-gov.offcampus.lib.washington.edu\/drugsatfda_docs\/label\/2019\/211321s000lbl.pdf. Accessed 17 Mar 2023."},{"key":"570_CR49","unstructured":"Freilich ER. Clinical Review. NDA 211321 Nayzilam (Intranasal midazolam). Center for Drug Evaluation and Research; 2019. p. 1\u201389."},{"issue":"9","key":"570_CR50","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1111\/epi.15159","volume":"60","author":"K Detyniecki","year":"2019","unstructured":"Detyniecki K, van Ess PJ, Sequeira DJ, et al. Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters\u2014a randomized, double-blind, placebo-controlled trial. Epilepsia. 2019;60(9):1797\u2013808. https:\/\/doi.org\/10.1111\/epi.15159.","journal-title":"Epilepsia"},{"key":"570_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2021.106567","volume":"171","author":"MR Bouw","year":"2021","unstructured":"Bouw MR, Chung SS, Gidal B, et al. Clinical pharmacokinetic and pharmacodynamic profile of midazolam nasal spray. Epilepsy Res. 2021;171: 106567. https:\/\/doi.org\/10.1016\/j.eplepsyres.2021.106567.","journal-title":"Epilepsy Res"},{"key":"570_CR52","doi-asserted-by":"publisher","unstructured":"McTagueA, Martland T, Appleton R. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev. 2018:(1):CD001905. https:\/\/doi.org\/10.1002\/14651858.CD001905.pub3.","DOI":"10.1002\/14651858.CD001905.pub3"},{"issue":"9","key":"570_CR53","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa002141","volume":"345","author":"BK Alldredge","year":"2001","unstructured":"Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345(9):631\u20137. https:\/\/doi.org\/10.1056\/NEJMoa002141.","journal-title":"N Engl J Med"},{"issue":"16","key":"570_CR54","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1001\/jama.2014.2625","volume":"311","author":"JM Chamberlain","year":"2014","unstructured":"Chamberlain JM, Okada P, Holsti M, et al. Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial. JAMA. 2014;311(16):1652\u201360. https:\/\/doi.org\/10.1001\/jama.2014.2625.","journal-title":"JAMA"},{"issue":"7","key":"570_CR55","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJMoa1107494","volume":"366","author":"R Silbergleit","year":"2012","unstructured":"Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366(7):591\u2013600. https:\/\/doi.org\/10.1056\/NEJMoa1107494.","journal-title":"N Engl J Med"},{"issue":"1","key":"570_CR56","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1542\/peds.2007-0930","volume":"121","author":"A Mpimbaza","year":"2008","unstructured":"Mpimbaza A, Ndeezi G, Staedke S, et al. Comparison of buccal midazolam with rectal diazepam in the treatment of prolonged seizures in Ugandan children: a randomized clinical trial. Pediatrics. 2008;121(1):e58\u201364. https:\/\/doi.org\/10.1542\/peds.2007-0930.","journal-title":"Pediatrics"},{"key":"570_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108390","volume":"125","author":"R Chhabra","year":"2021","unstructured":"Chhabra R, Gupta R, Gupta LK. Intranasal midazolam versus intravenous\/rectal benzodiazepines for acute seizure control in children: a systematic review and meta-analysis. Epilepsy Behav. 2021;125: 108390. https:\/\/doi.org\/10.1016\/j.yebeh.2021.108390.","journal-title":"Epilepsy Behav."},{"issue":"9","key":"570_CR58","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1177\/0883073816638757","volume":"31","author":"Z-Y Zhao","year":"2016","unstructured":"Zhao Z-Y, Wang H-Y, Wen B, et al. A comparison of midazolam, lorazepam, and diazepam for the treatment of status epilepticus in children: a network meta-analysis. J Child Neurol. 2016;31(9):1093\u2013107. https:\/\/doi.org\/10.1177\/0883073816638757.","journal-title":"J Child Neurol"},{"issue":"10231","key":"570_CR59","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","volume":"395","author":"JM Chamberlain","year":"2020","unstructured":"Chamberlain JM, Kapur J, Shinnar S, et al. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet. 2020;395(10231):1217\u201324. https:\/\/doi.org\/10.1016\/S0140-6736(20)30611-5.","journal-title":"Lancet"},{"issue":"10186","key":"570_CR60","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/S0140-6736(19)30722-6","volume":"393","author":"SR Dalziel","year":"2019","unstructured":"Dalziel SR, Borland ML, Furyk J, et al. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (andomi): an open-label, multicentre, andomized controlled trial. Lancet. 2019;393(10186):2135\u201345. https:\/\/doi.org\/10.1016\/S0140-6736(19)30722-6.","journal-title":"Lancet"},{"issue":"10186","key":"570_CR61","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/S0140-6736(19)30724-X","volume":"393","author":"MD Lyttle","year":"2019","unstructured":"Lyttle MD, Rainford NEA, Gamble C, et al. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial. Lancet. 2019;393(10186):2125\u201334. https:\/\/doi.org\/10.1016\/S0140-6736(19)30724-X.","journal-title":"Lancet"},{"key":"570_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00506","author":"RJ Burman","year":"2019","unstructured":"Burman RJ, Ackermann S, Shapson-Coe A, et al. A comparison of parenteral phenobarbital vs. parenteral phenytoin as second-line management for pediatric convulsive status epilepticus in a resource-limited setting. Front Neurol. 2019. https:\/\/doi.org\/10.3389\/fneur.2019.00506.","journal-title":"Front Neurol"},{"issue":"20","key":"570_CR63","doi-asserted-by":"publisher","first-page":"e2339","DOI":"10.1212\/WNL.0000000000007503","volume":"92","author":"I S\u00e1nchez Fern\u00e1ndez","year":"2019","unstructured":"S\u00e1nchez Fern\u00e1ndez I, Ga\u00ednza-Lein M, Lamb N, et al. Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus. Neurology. 2019;92(20):e2339\u201348. https:\/\/doi.org\/10.1212\/WNL.0000000000007503.","journal-title":"Neurology"},{"issue":"5","key":"570_CR64","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ejpn.2012.01.012","volume":"16","author":"RA Malamiri","year":"2012","unstructured":"Malamiri RA, Ghaempanah M, Khosroshahi N, et al. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial. Eur J Paediatr Neurol. 2012;16(5):536\u201341. https:\/\/doi.org\/10.1016\/j.ejpn.2012.01.012.","journal-title":"Eur J Paediatr Neurol"},{"issue":"6","key":"570_CR65","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S1525-5050(02)00538-3","volume":"3","author":"JM Pellock","year":"2002","unstructured":"Pellock JM. Treatment considerations: traditional antiepileptic drugs. Epilepsy Behav. 2002;3(6):18\u201323. https:\/\/doi.org\/10.1016\/S1525-5050(02)00538-3.","journal-title":"Epilepsy Behav"},{"issue":"4","key":"570_CR66","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s13181-015-0490-z","volume":"11","author":"LA Garbovsky","year":"2015","unstructured":"Garbovsky LA, Drumheller BC, Perrone J. Purple glove syndrome after phenytoin or fosphenytoin administration: review of reported cases and recommendations for prevention. J Med Toxicol. 2015;11(4):445\u201359. https:\/\/doi.org\/10.1007\/s13181-015-0490-z.","journal-title":"J Med Toxicol"},{"issue":"8","key":"570_CR67","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1592\/phco.20.11.908.35269","volume":"20","author":"DR Touchette","year":"2000","unstructured":"Touchette DR, Rhoney DH. Cost-minimization analysis of phenytoin and fosphenytoin in the emergency department. Pharmacotherapy. 2000;20(8):908\u201316. https:\/\/doi.org\/10.1592\/phco.20.11.908.35269.","journal-title":"Pharmacotherapy"},{"issue":"6","key":"570_CR68","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2165\/00002018-200022060-00004","volume":"22","author":"JC DeToledo","year":"2000","unstructured":"DeToledo JC, Ramsay RE. Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs. Drug Saf. 2000;22(6):459\u201366. https:\/\/doi.org\/10.2165\/00002018-200022060-00004.","journal-title":"Drug Saf"},{"key":"570_CR69","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.seizure.2021.07.012","volume":"91","author":"Y Feng","year":"2021","unstructured":"Feng Y, Chen Y, Jia Y, et al. Efficacy and safety of levetiracetam versus (fos)phenytoin for second-line treatment of epilepticus: a meta-analysis of latest randomized controlled trials. Seizure. 2021;91:339\u201345. https:\/\/doi.org\/10.1016\/j.seizure.2021.07.012.","journal-title":"Seizure."},{"issue":"12","key":"570_CR70","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s40263-020-00770-0","volume":"34","author":"T Xue","year":"2020","unstructured":"Xue T, Wei L, Shen X, et al. Levetiracetam versus phenytoin for the pharmacotherapy of benzodiazepine-refractory status epilepticus: a systematic review and meta-analysis of randomized controlled trials. CNS Drugs. 2020;34(12):1205\u201315. https:\/\/doi.org\/10.1007\/s40263-020-00770-0.","journal-title":"CNS Drugs"},{"issue":"9","key":"570_CR71","doi-asserted-by":"publisher","first-page":"e480","DOI":"10.1097\/PCC.0000000000002703","volume":"22","author":"JA Klowak","year":"2021","unstructured":"Klowak JA, Hewitt M, Catenacci V, et al. Levetiracetam versus phenytoin or fosphenytoin for second-line treatment of pediatric status epilepticus: a meta-analysis. Pediatr Crit Care Med. 2021;22(9):e480\u201391. https:\/\/doi.org\/10.1097\/PCC.0000000000002703.","journal-title":"Pediatr Crit Care Med"},{"key":"570_CR72","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmab014","author":"SK Angurana","year":"2021","unstructured":"Angurana SK, Suthar R. Efficacy and safety of levetiracetam vs. phenytoin as second line antiseizure medication for pediatric convulsive status epilepticus: a systematic review and meta-analysis of randomized controlled trials. J Trop Pediatr. 2021. https:\/\/doi.org\/10.1093\/tropej\/fmab014.","journal-title":"J Trop Pediatr."},{"issue":"1","key":"570_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40261-020-00975-7","volume":"41","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Liu Y, Liao Q, Liu Z. Preferential antiseizure medications in pediatric patients with convulsive status epilepticus: a systematic review and network meta-analysis. Clin Drug Investig. 2021;41(1):1\u201317. https:\/\/doi.org\/10.1007\/s40261-020-00975-7.","journal-title":"Clin Drug Investig"},{"issue":"3","key":"570_CR74","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s13312-020-1755-4","volume":"57","author":"V Vignesh","year":"2020","unstructured":"Vignesh V, Rameshkumar R, Mahadevan S. Comparison of phenytoin, valproate and levetiracetam in pediatric convulsive status epilepticus: a randomized double-blind controlled clinical trial. Indian Pediatr. 2020;57(3):222\u20137.","journal-title":"Indian Pediatr"},{"issue":"6","key":"570_CR75","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/epi.13716","volume":"58","author":"A Strzelczyk","year":"2017","unstructured":"Strzelczyk A, Z\u00f6llner JP, Willems LM, et al. Lacosamide in status epilepticus: systematic review of current evidence. Epilepsia. 2017;58(6):933\u201350. https:\/\/doi.org\/10.1111\/epi.13716.","journal-title":"Epilepsia"},{"key":"570_CR76","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.yebeh.2017.07.005","volume":"76","author":"UK Misra","year":"2017","unstructured":"Misra UK, Dubey D, Kalita J. Comparison of lacosamide versus sodium valproate in status epilepticus: a pilot study. Epilepsy Behav. 2017;76:110\u20133. https:\/\/doi.org\/10.1016\/j.yebeh.2017.07.005.","journal-title":"Epilepsy Behav"},{"issue":"4","key":"570_CR77","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/ane.13469","volume":"144","author":"PK Panda","year":"2021","unstructured":"Panda PK, Panda P, Dawman L, et al. Efficacy of lacosamide and phenytoin in status epilepticus: a systematic review. Acta Neurol Scand. 2021;144(4):366\u201374. https:\/\/doi.org\/10.1111\/ane.13469.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"570_CR78","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5334\/ijic.5598","volume":"22","author":"MC Jackson","year":"2022","unstructured":"Jackson MC, Vasquez A, Ojo O, et al. Identifying barriers to care in the pediatric acute seizure care pathway. Int J Integr Care. 2022;22(1):28. https:\/\/doi.org\/10.5334\/ijic.5598.","journal-title":"Int J Integr Care."},{"key":"570_CR79","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pediatrneurol.2020.04.005","volume":"112","author":"KL Neville","year":"2020","unstructured":"Neville KL, McCaffery H, Baxter Z, et al. Implementation of a standardized seizure action plan to improve communication and parental education. Pediatr Neurol. 2020;112:56\u201363. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2020.04.005.","journal-title":"Pediatr Neurol"},{"key":"570_CR80","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.seizure.2017.10.007","volume":"52","author":"M Ga\u00ednza-Lein","year":"2017","unstructured":"Ga\u00ednza-Lein M, Benjamin R, Stredny C, et al. Rescue medications in epilepsy patients: a family perspective. Seizure. 2017;52:188\u201394. https:\/\/doi.org\/10.1016\/j.seizure.2017.10.007.","journal-title":"Seizure."},{"key":"570_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108264","volume":"123","author":"P Penovich","year":"2021","unstructured":"Penovich P, Glauser T, Becker D, et al. Recommendations for development of acute seizure action plans (ASAPs) from an expert panel. Epilepsy Behav. 2021;123: 108264. https:\/\/doi.org\/10.1016\/j.yebeh.2021.108264.","journal-title":"Epilepsy Behav."},{"issue":"4","key":"570_CR82","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/0883073815597755","volume":"31","author":"LM Roundy","year":"2016","unstructured":"Roundy LM, Filloux FM, Kerr L, et al. Seizure action plans do not reduce health care utilization in pediatric epilepsy patients. J Child Neurol. 2016;31(4):433\u20138. https:\/\/doi.org\/10.1177\/0883073815597755.","journal-title":"J Child Neurol"},{"issue":"11","key":"570_CR83","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1177\/0883073819846810","volume":"34","author":"DVF Albert","year":"2019","unstructured":"Albert DVF, Moreland JJ, Salvator A, et al. Seizure action plans for pediatric patients with epilepsy: a randomized controlled trial. J Child Neurol. 2019;34(11):666\u201373. https:\/\/doi.org\/10.1177\/0883073819846810.","journal-title":"J Child Neurol"},{"issue":"6","key":"570_CR84","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1177\/1942602X211026333","volume":"36","author":"P Dean","year":"2021","unstructured":"Dean P, O\u2019Hara K, Brooks L, et al. Managing acute seizures: new rescue delivery option and resources to assist school nurses. NASN Sch Nurse. 2021;36(6):346\u201354. https:\/\/doi.org\/10.1177\/1942602X211026333.","journal-title":"NASN Sch Nurse"},{"key":"570_CR85","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3876","author":"AL Hartman","year":"2016","unstructured":"Hartman AL, Devore CDL, Section on Neurology, American Academy of Pediatrics: Council on School Health, American Academy of Pediatrics, Doerrer SC. Rescue medicine for epilepsy in education settings. Pediatrics. 2016. https:\/\/doi.org\/10.1542\/peds.2015-3876.","journal-title":"Pediatrics"},{"issue":"Pt A","key":"570_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2020.107649","volume":"114","author":"NT Cohen","year":"2021","unstructured":"Cohen NT. Toward the adoption of a Federal seizure action plan. Epilepsy Behav. 2021;114(Pt A): 107649. https:\/\/doi.org\/10.1016\/j.yebeh.2020.107649.","journal-title":"Epilepsy Behav."},{"key":"570_CR87","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jpeds.2019.05.034","volume":"212","author":"A Wallace","year":"2019","unstructured":"Wallace A, Wirrell E, Payne E. Seizure rescue medication use among US pediatric epilepsy providers: a survey of the pediatric epilepsy research consortium. J Pediatr. 2019;212:111\u20136. https:\/\/doi.org\/10.1016\/j.jpeds.2019.05.034.","journal-title":"J Pediatr"},{"issue":"9","key":"570_CR88","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1177\/0883073807306254","volume":"22","author":"D Terry","year":"2007","unstructured":"Terry D, Paolicchi J, Karn M. Acceptance of the use of diazepam rectal gel in school and day care settings. J Child Neurol. 2007;22(9):1135\u20138. https:\/\/doi.org\/10.1177\/0883073807306254.","journal-title":"J Child Neurol"},{"issue":"9","key":"570_CR89","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s00431-016-2750-6","volume":"175","author":"A Kaune","year":"2016","unstructured":"Kaune A, Schumacher PM, Hope SC, et al. Administration of anticonvulsive rescue medication in children-discrepancies between parents\u2019 self-reports and limited practical performance. Eur J Pediatr. 2016;175(9):1139\u201346. https:\/\/doi.org\/10.1007\/s00431-016-2750-6.","journal-title":"Eur J Pediatr"},{"key":"570_CR90","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.seizure.2018.04.011","volume":"58","author":"CM Stredny","year":"2018","unstructured":"Stredny CM, Abend NS, Loddenkemper T. Towards acute pediatric status epilepticus intervention teams: do we need \u2018seizure codes\u2019? Seizure. 2018;58:133\u201340. https:\/\/doi.org\/10.1016\/j.seizure.2018.04.011.","journal-title":"Seizure."},{"issue":"2","key":"570_CR91","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.yebeh.2003.12.012","volume":"5","author":"JM Pellock","year":"2004","unstructured":"Pellock JM, Marmarou A, DeLorenzo R. Time to treatment in prolonged seizure episodes. Epilepsy Behav. 2004;5(2):192\u20136. https:\/\/doi.org\/10.1016\/j.yebeh.2003.12.012.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"570_CR92","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/ejhpharm-2021-002721","volume":"30","author":"K Srivastava","year":"2023","unstructured":"Srivastava K, Suryawanshi VR, Yerrapalam N, et al. Compliance with status epilepticus management protocol and effect on clinical outcomes in children with status epilepticus. Eur J Hosp Pharm. 2023;30(3):147\u201352. https:\/\/doi.org\/10.1136\/ejhpharm-2021-002721.","journal-title":"Eur J Hosp Pharm"},{"issue":"12","key":"570_CR93","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1111\/jpc.14448","volume":"55","author":"P Uppal","year":"2019","unstructured":"Uppal P, Cardamone M, Webber C, et al. Management of status epilepticus in children prior to medical retrieval: deviations from the guidelines. J Paediatr Child Health. 2019;55(12):1458\u201362. https:\/\/doi.org\/10.1111\/jpc.14448.","journal-title":"J Paediatr Child Health"},{"issue":"2","key":"570_CR94","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/jpc.15697","volume":"58","author":"P Uppal","year":"2022","unstructured":"Uppal P, Cardamone M, Fonseca B, et al. The need for improved management of status epilepticus in children in Australia: time from seizure onset to treatment is consistently delayed. J Paediatr Child Health. 2022;58(2):261\u20136. https:\/\/doi.org\/10.1111\/jpc.15697.","journal-title":"J Paediatr Child Health"},{"issue":"8","key":"570_CR95","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1212\/01.wnl.0000180959.31355.92","volume":"65","author":"K Eriksson","year":"2005","unstructured":"Eriksson K, Mets\u00e4ranta P, Huhtala H, et al. Treatment delay and the risk of prolonged status epilepticus. Neurology. 2005;65(8):1316\u20138. https:\/\/doi.org\/10.1212\/01.wnl.0000180959.31355.92.","journal-title":"Neurology"},{"issue":"1","key":"570_CR96","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1742-6723.2006.00807.x","volume":"18","author":"S Lewena","year":"2006","unstructured":"Lewena S, Young S. When benzodiazepines fail: how effective is second line therapy for status epilepticus in children? Emerg Med Australas. 2006;18(1):45\u201350. https:\/\/doi.org\/10.1111\/j.1742-6723.2006.00807.x.","journal-title":"Emerg Med Australas"},{"key":"570_CR97","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.4382","author":"M Ga\u00ednza-Lein","year":"2018","unstructured":"Ga\u00ednza-Lein M, S\u00e1nchez Fern\u00e1ndez I, Jackson M, et al. Association of time to treatment with short-term outcomes for pediatric patients with refractory convulsive status epilepticus. JAMA Neurol. 2018. https:\/\/doi.org\/10.1001\/jamaneurol.2017.4382.","journal-title":"JAMA Neurol"},{"issue":"8","key":"570_CR98","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S1474-4422(08)70141-8","volume":"7","author":"RFM Chin","year":"2008","unstructured":"Chin RFM, Neville BGR, Peckham C, et al. Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study. Lancet Neurol. 2008;7(8):696\u2013703. https:\/\/doi.org\/10.1016\/S1474-4422(08)70141-8.","journal-title":"Lancet Neurol"},{"issue":"3","key":"570_CR99","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0887-8994(95)00044-g","volume":"12","author":"BK Alldredge","year":"1995","unstructured":"Alldredge BK, Wall DB, Ferriero DM. Effect of prehospital treatment on the outcome of status epilepticus in children. Pediatr Neurol. 1995;12(3):213\u20136. https:\/\/doi.org\/10.1016\/0887-8994(95)00044-g.","journal-title":"Pediatr Neurol"},{"issue":"Suppl 1","key":"570_CR100","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3109\/10903127.2013.844874","volume":"18","author":"MI Shah","year":"2014","unstructured":"Shah MI, Macia CG, Dayan PS, et al. An evidence-based guideline for pediatric prehospital seizure management using GRADE methodology. Prehosp Emerg Care. 2014;18(Suppl 1):15\u201324. https:\/\/doi.org\/10.3109\/10903127.2013.844874.","journal-title":"Prehosp Emerg Care"},{"issue":"3","key":"570_CR101","doi-asserted-by":"publisher","first-page":"419","DOI":"10.5811\/westjem.2016.12.32066","volume":"18","author":"EC Silverman","year":"2017","unstructured":"Silverman EC, Sporer KA, Lemieux JM, et al. Prehospital care for the adult and pediatric seizure patient: current evidence-based recommendations. West J Emerg Med. 2017;18(3):419\u201336. https:\/\/doi.org\/10.5811\/westjem.2016.12.32066.","journal-title":"West J Emerg Med"},{"issue":"12","key":"570_CR102","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1001\/jama.2019.0441","volume":"321","author":"JP Betjemann","year":"2019","unstructured":"Betjemann JP, Josephson SA, Lowenstein DH, et al. Emergency medical services protocols for generalized convulsive status epilepticus. JAMA. 2019;321(12):1216\u20137. https:\/\/doi.org\/10.1001\/jama.2019.0441.","journal-title":"JAMA"},{"issue":"6","key":"570_CR103","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1080\/10903127.2019.1595234","volume":"23","author":"JM Carey","year":"2019","unstructured":"Carey JM, Studnek JR, Browne LR, et al. Paramedic-identified enablers of and barriers to pediatric seizure management: a multicenter, qualitative study. Prehosp Emerg Care. 2019;23(6):870\u201381. https:\/\/doi.org\/10.1080\/10903127.2019.1595234.","journal-title":"Prehosp Emerg Care."},{"issue":"19","key":"570_CR104","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1001\/jama.2021.15964","volume":"326","author":"EL Guterman","year":"2021","unstructured":"Guterman EL, Burke JF, Sporer KA. Prehospital treatment of status epilepticus in the United States. JAMA. 2021;326(19):1970\u20131. https:\/\/doi.org\/10.1001\/jama.2021.15964.","journal-title":"JAMA"},{"issue":"3","key":"570_CR105","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/ana.2598","volume":"89","author":"EJ Han","year":"2021","unstructured":"Han EJ, Chuck CC, Martin TJ, et al. Statewide emergency medical services protocols for status epilepticus management. Ann Neurol. 2021;89(3):604\u20139. https:\/\/doi.org\/10.1002\/ana.2598.","journal-title":"Ann Neurol"},{"issue":"3","key":"570_CR106","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/archpedi.157.3.229","volume":"157","author":"AN Shah","year":"2003","unstructured":"Shah AN, Frush K, Luo X, et al. Effect of an intervention standardization system on pediatric dosing and equipment size determination: a crossover trial involving simulated resuscitation events. Arch Pediatr Adolesc Med. 2003;157(3):229\u201336. https:\/\/doi.org\/10.1001\/archpedi.157.3.229.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"8","key":"570_CR107","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/j.1553-2712.2002.tb02175.x","volume":"9","author":"R Luten","year":"2002","unstructured":"Luten R, Wears RL, Broselow J, et al. Managing the unique size-related issues of pediatric resuscitation: reducing cognitive load with resuscitation aids. Acad Emerg Med. 2002;9(8):840\u20137. https:\/\/doi.org\/10.1111\/j.1553-2712.2002.tb02175.x.","journal-title":"Acad Emerg Med."},{"issue":"3","key":"570_CR108","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2018-000534","volume":"8","author":"B Woods","year":"2019","unstructured":"Woods B, Lang B, Blayney C, et al. Medic One Pediatric (MOPed) cards: standardising paramedic paediatric resuscitation. BMJ Open Qual. 2019;8(3): e000534. https:\/\/doi.org\/10.1136\/bmjoq-2018-000534.","journal-title":"BMJ Open Qual."},{"key":"570_CR109","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.10.001","volume":"126","author":"JC Keene","year":"2022","unstructured":"Keene JC, Woods B, Wainwright M, et al. Optimized benzodiazepine treatment of pediatric status epilepticus through a standardized emergency medical services resuscitation tool. Pediatr Neurol. 2022;126:50\u20135. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2021.10.001.","journal-title":"Pediatr Neurol"},{"key":"570_CR110","unstructured":"M. Shah. Pediatric Dose Optimization for Seizures in Emergency Medical Services (PediDOSE). 2021. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT05121324."},{"key":"570_CR111","unstructured":"Seattle Children\u2019s Hospital, Morgan L, Abrams L, et al. Seizure critical care pathway. 2021. https:\/\/www.seattlechildrens.org\/pdf\/seizure-pathway.pdf."},{"key":"570_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2018.05.012","author":"AP Ostendorf","year":"2018","unstructured":"Ostendorf AP, Merison K, Wheeler TA, et al. Decreasing seizure treatment time through quality improvement reduces critical care utilization. Pediatr Neurol. 2018. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2018.05.012.","journal-title":"Pediatr Neurol."},{"key":"570_CR113","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.seizure.2020.08.011","volume":"81","author":"SP Trau","year":"2020","unstructured":"Trau SP, Sterrett EC, Feinstein L, et al. Institutional pediatric convulsive status epilepticus protocol decreases time to first and second line anti-seizure medication administration. Seizure. 2020;81:263\u20138. https:\/\/doi.org\/10.1016\/j.seizure.2020.08.011.","journal-title":"Seizure."},{"issue":"10","key":"570_CR114","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1111\/epi.17026","volume":"62","author":"J Vidaurre","year":"2021","unstructured":"Vidaurre J, Albert DVF, Parker W, et al. Improving time for administration of second-line antiseizure medications for children with generalized convulsive status epilepticus using quality improvement methodology. Epilepsia. 2021;62(10):2496\u2013504. https:\/\/doi.org\/10.1111\/epi.17026.","journal-title":"Epilepsia"},{"key":"570_CR115","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000001816","author":"G Cassel-Choudhury","year":"2019","unstructured":"Cassel-Choudhury G, Beal J, Longani N, et al. Protocol-driven management of convulsive status epilepticus at a tertiary children\u2019s hospital. Pediatr Crit Care Med. 2019. https:\/\/doi.org\/10.1097\/PCC.0000000000001816.","journal-title":"Pediatr Crit Care Med."},{"key":"570_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2018.06.004","author":"A Vasquez","year":"2018","unstructured":"Vasquez A, Ga\u00ednza-Lein M, S\u00e1nchez Fern\u00e1ndez I, et al. Hospital emergency treatment of convulsive status epilepticus: comparison of pathways from ten pediatric research centers. Pediatr Neurol. 2018. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2018.06.004.","journal-title":"Pediatr Neurol."},{"issue":"8","key":"570_CR117","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/acem.13811","volume":"26","author":"AG Sathe","year":"2019","unstructured":"Sathe AG, Underwood E, Coles LD, et al. Underdosing of benzodiazepines in patients with status epilepticus enrolled in established status epilepticus treatment trial. Acad Emerg Med. 2019;26(8):940\u20133. https:\/\/doi.org\/10.1111\/acem.13811.","journal-title":"Acad Emerg Med"},{"issue":"8","key":"570_CR118","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1111\/epi.12235","volume":"54","author":"M Spatola","year":"2013","unstructured":"Spatola M, Alvarez V, Rossetti AO. Benzodiazepine overtreatment in status epilepticus is related to higher need of intubation and longer hospitalization. Epilepsia. 2013;54(8):e99\u2013102. https:\/\/doi.org\/10.1111\/epi.12235.","journal-title":"Epilepsia"},{"issue":"9","key":"570_CR119","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.seizure.2009.07.006","volume":"18","author":"S Tirupathi","year":"2009","unstructured":"Tirupathi S, McMenamin JB, Webb DW. Analysis of factors influencing admission to intensive care following convulsive status epilepticus in children. Seizure. 2009;18(9):630\u20133. https:\/\/doi.org\/10.1016\/j.seizure.2009.07.006.","journal-title":"Seizure."},{"issue":"Suppl 2","key":"570_CR120","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/epi.14484","volume":"59","author":"B Lee","year":"2018","unstructured":"Lee B, Asian Status Epilepticus Survey Group. Treatment gap for convulsive status epilepticus in resource-poor countries. Epilepsia. 2018;59(Suppl 2):135\u20139. https:\/\/doi.org\/10.1111\/epi.14484.","journal-title":"Epilepsia"},{"key":"570_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108408","volume":"125","author":"C Marshall","year":"2021","unstructured":"Marshall C, Olaniyah T, Jalloh AA, et al. Survey of the perceived treatment gap in status epilepticus care across Sub-Saharan countries from the perspective of healthcare providers. Epilepsy Behav. 2021;125: 108408. https:\/\/doi.org\/10.1016\/j.yebeh.2021.108408.","journal-title":"Epilepsy Behav."},{"issue":"7","key":"570_CR122","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41582-022-00664-3","volume":"18","author":"RJ Burman","year":"2022","unstructured":"Burman RJ, Rosch RE, Wilmshurst JM, et al. Why won\u2019t it stop? The dynamics of benzodiazepine resistance in status epilepticus. Nat Rev Neurol. 2022;18(7):428\u201341. https:\/\/doi.org\/10.1038\/s41582-022-00664-3.","journal-title":"Nat Rev Neurol"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-023-00570-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-023-00570-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-023-00570-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T13:23:14Z","timestamp":1687353794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-023-00570-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,13]]},"references-count":122,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["570"],"URL":"https:\/\/doi.org\/10.1007\/s40272-023-00570-1","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,13]]},"assertion":[{"value":"28 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Funding was not received for the publication of this review article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Lindsey A. Morgan, Jennifer B. Hrachovec, and Howard P. Goodkin declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Lindsey A. Morgan and Howard P. Goodkin developed the idea and participated equally in the drafting of this review. Jennifer B. Hrachovec provided critical revisions and edits. All authors read and approved the final version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}